Caraco Laboratories v. Novo Nordisk

Case Term	OT 2011
Category	Business Law
Question Presented	Whether a generic drug manufacturer may sue the company that produces the brand-name version of the drug to require it to correct information filed with the FDA that is relevant to the agency’s decision whether to approve the generic version of the drug.
Lower Court's Decision	No
Research for TWEN users by Westlaw	Oral Argument Transcript Merit Briefs: Brief for Petitioner Brief for Respondent Reply Brief for Petitioner Certiorari-Stage Documents: Opinion below Petitioner for Certiorari Brief in Opposition